Detectiome has been awarded the “Most Impactful Business” in the MBRIF Demo Day | Cohort 7
On May 1, 2024, the Mohammed Bin Rashid Innovation Fund (MBRIF) hosted the Demo Day for the seventh cohort of
Revolutionizing Cancer Diagnostics: The Power of Liquid Biopsy MCED (REVONCO) vs. Genetic Testing
Advancements in medical science have led to the development of various tools and techniques for early cancer detection and risk
Revonco: Transforming Cancer Care in the Middle East with Multi-Cancer Early Detection
We are thrilled to unveil a groundbreaking advancement in cancer screening with the launch our Multi-Cancer Early Detection, Revonco, the
Detectiome Unveils Revonco: The First Multi-Cancer Early Detection Super Test Optimized for the Middle Eastern Genetics
Dubai, UAE October 17th, 2023: Detectiome today announced the first version of its flagship Multi-Cancer Early Detection (MCED): Revonco. Revonco
Detectiome was one of the leading Science based startups in the opening of in5 Science, a new vertical from in5 and Dubai Science Park
Celebrating a Decade in the UAE’s Entrepreneurial Ecosystem, in5 Dubai Expands its Support for Science-based Startups. Dubai, UAE – In
Detectiome has been selected as one of the top 3 startups to represent Dubai startup ecosystem in VIVA TECHNOLOGY 2023 Paris
Detectiome has proudly been chosen as one of the three startups to represent the dynamic Dubai Startup Ecosystem at Viva
Are You at High Risk for Cancer? Check if You Have Any of These Risk Factors!
Several factors can increase a person’s risk of developing cancer. Some of these factors include: Age: As people get older,